Your browser doesn't support javascript.
loading
Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.
Lue, Yanhe; Gao, Chen; Swerdloff, Ronald; Hoang, James; Avetisyan, Rozeta; Jia, Yue; Rao, Meng; Ren, Shuxun; Atienza, Vince; Yu, Junyi; Zhang, Ye; Chen, Mengping; Song, Yang; Wang, Yibin; Wang, Christina.
Affiliation
  • Lue Y; Division of Endocrinology, Department of Medicine, Los Angeles Biomedical Research Institute and Harbor-UCLA Medical Center, University of California-Los Angeles, Torrance, California.
  • Gao C; Division of Molecular Medicine, Department of Anesthesiology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California.
  • Swerdloff R; Division of Endocrinology, Department of Medicine, Los Angeles Biomedical Research Institute and Harbor-UCLA Medical Center, University of California-Los Angeles, Torrance, California.
  • Hoang J; Division of Endocrinology, Department of Medicine, Los Angeles Biomedical Research Institute and Harbor-UCLA Medical Center, University of California-Los Angeles, Torrance, California.
  • Avetisyan R; Division of Molecular Medicine, Department of Anesthesiology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California.
  • Jia Y; Division of Endocrinology, Department of Medicine, Los Angeles Biomedical Research Institute and Harbor-UCLA Medical Center, University of California-Los Angeles, Torrance, California.
  • Rao M; Division of Endocrinology, Department of Medicine, Los Angeles Biomedical Research Institute and Harbor-UCLA Medical Center, University of California-Los Angeles, Torrance, California.
  • Ren S; Division of Molecular Medicine, Department of Anesthesiology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California.
  • Atienza V; Division of Endocrinology, Department of Medicine, Los Angeles Biomedical Research Institute and Harbor-UCLA Medical Center, University of California-Los Angeles, Torrance, California.
  • Yu J; Division of Molecular Medicine, Department of Anesthesiology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California.
  • Zhang Y; Department of Cardiology, Chongqing Institute of Cardiology and Chongqing Cardiovascular Clinical Research Center, Daping Hospital, Third Military Medical University , Chongqing , China.
  • Chen M; Division of Molecular Medicine, Department of Anesthesiology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California.
  • Song Y; Department of Cardiology, Chongqing Institute of Cardiology and Chongqing Cardiovascular Clinical Research Center, Daping Hospital, Third Military Medical University , Chongqing , China.
  • Wang Y; Division of Molecular Medicine, Department of Anesthesiology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California.
  • Wang C; Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis, Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine , Shanghai , China.
Am J Physiol Heart Circ Physiol ; 315(3): H634-H643, 2018 09 01.
Article in En | MEDLINE | ID: mdl-29775411

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiotonic Agents / Myocytes, Cardiac / Intracellular Signaling Peptides and Proteins / Dexrazoxane Limits: Animals Language: En Journal: Am J Physiol Heart Circ Physiol Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2018 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiotonic Agents / Myocytes, Cardiac / Intracellular Signaling Peptides and Proteins / Dexrazoxane Limits: Animals Language: En Journal: Am J Physiol Heart Circ Physiol Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2018 Document type: Article Country of publication: United States